eVLPs are an innovative new class of synthetic vaccines that are designed to closely mimic the structure of viruses.

Because of their structural similarity to viruses found in nature, vaccination with a target protein expressed in an eVLP is capable of imparting greater immunity than vaccination with the same recombinant target protein alone.

Structure of the eVLP platform generates stronger neutralizing antibodies than does immunization with the same (gB) target protein alone.